Novel Inhibitors of Retroviral Reverse Transcriptase
Disclosed are nucleic acid molecules, and methods of their use, which have a specific structure including a double helical domain and a G-quadruplex domain physically connected by a linker domain which may be nucleosidic or non-nucleosidic. These aptamers demonstrate potent inhibition of phylogenetically diverse primate lentiviral reverse transcriptases, which effect is largely independent of aptamer sequence provided that the aptamer has the specified structure.
MICHALOWSKI DANIEL [US]; BURKE-AGUERO DONALD H [US]
Type of Offer:
« More Biotech Patents